MUCOCUTANEOUS MANIFESTATIONS OF LYMPHOMAS AND LEUKEMIAS IN BLACK KENYAN CHILDREN

被引:6
|
作者
RIYAT, MS [1 ]
机构
[1] NAIROBI HOSP,DEPT HEMATOL,NAIROBI,KENYA
关键词
D O I
10.1111/j.1365-4362.1995.tb01590.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background. Childhood leukemia and lymphoma are common problems in Tropical Africa, including Kenya. Studies done in Western populations indicate that 25-50% of patients with leukemia and lymphoma have specific or nonspecific cutaneous signs. In dark-skinned patients, reports of such mucocutaneous manifestations are scarce. The lesions in these patients may easily be missed, if not specifically looked for. Method. Eighty-six indigenous Kenyan children with a confirmed diagnosis of leukemia or lymphoma were specifically examined for any mucocutaneous manifestations at presentation, during their treatment, and during subsequent follow-up. Whenever possible, an attempt was made to determine the causes of these lesions. All patients were given standard therapy for the primary hematologic disorder. Results. Two-thirds of the patients had mucocutaneous symptomatology at presentation: 17.4% had skin infiltration by the malignant cells. During therapy an even larger number developed nonspecific skin manifestations. Most of these were the result of myelosuppression, immunosuppression, or direct cytotoxic effects on tissues. Conclusions. Mucocutaneous manifestations in black children with leukemia and lymphoma are very common.
引用
收藏
页码:249 / 255
页数:7
相关论文
共 50 条
  • [31] MUCOCUTANEOUS MANIFESTATIONS OF HIV INFECTION
    HERBST, JS
    RESNICK, L
    CLINICS IN DERMATOLOGY, 1989, 7 (01) : 56 - &
  • [32] MicroRNAs in the ontogeny of leukemias and lymphomas
    Fabbri, Muller
    Croce, Carlo M.
    Calin, George A.
    LEUKEMIA & LYMPHOMA, 2009, 50 (02) : 160 - 170
  • [33] DEOXYCOFORMYCIN IN THE TREATMENT OF LEUKEMIAS AND LYMPHOMAS
    SMYTH, JF
    PRENTICE, HG
    PROCTOR, S
    HOFFBRAND, AV
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1985, 451 (OCT) : 123 - 128
  • [34] VINCRISTINE IN TREATMENT OF LYMPHOMAS AND LEUKEMIAS
    BOHANNON, RA
    DIAMOND, HD
    MILLER, DG
    CANCER RESEARCH, 1963, 23 (04) : 613 - +
  • [35] LEUKEMIAS AND LYMPHOMAS OF THYMIC DIFFERENTIATION
    BOROWITZ, MJ
    FALLETTA, JM
    CLINICS IN LABORATORY MEDICINE, 1988, 8 (01) : 119 - 134
  • [36] ACLACINOMYCIN A IN ACUTE LEUKEMIAS AND LYMPHOMAS
    MATHE, G
    GESCHER, F
    BAYSSAS, M
    MISSET, JL
    MACHOVER, D
    GIL, MA
    DELGADO, M
    RIBAUD, P
    HAYAT, M
    LANCET, 1979, 2 (8137): : 310 - 311
  • [37] Renal lesions in lymphomas/leukemias
    Seshan, SV
    UPDATE IN PATHOLOGY, PROCEEDINGS, 2003, : 305 - 307
  • [38] NEUROLOGIC COMPLICATIONS OF LEUKEMIAS AND LYMPHOMAS
    HUNT, WE
    BOURONCLE, BA
    MEAGHER, JN
    JOURNAL OF NEUROSURGERY, 1959, 16 (02) : 135 - 151
  • [39] Epigenetic Mechanisms in Leukemias and Lymphomas
    Duy, Cihangir
    Beguelin, Wendy
    Melnick, Ari
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2020, 10 (12): : 1 - 29
  • [40] ULTRASTRUCTURAL DIAGNOSIS OF LYMPHOMAS AND LEUKEMIAS
    MACKAY, B
    ULTRASTRUCTURAL PATHOLOGY, 1985, 9 (3-4) : 209 - 214